Advertisement
Research Article

Relacin, a Novel Antibacterial Agent Targeting the Stringent Response

  • Ezequiel Wexselblatt equal contributor,

    equal contributor Contributed equally to this work with: Ezequiel Wexselblatt, Yaara Oppenheimer-Shaanan, Ilana Kaspy

    Affiliation: Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Yaara Oppenheimer-Shaanan equal contributor,

    equal contributor Contributed equally to this work with: Ezequiel Wexselblatt, Yaara Oppenheimer-Shaanan, Ilana Kaspy

    Affiliation: Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Ilana Kaspy equal contributor,

    equal contributor Contributed equally to this work with: Ezequiel Wexselblatt, Yaara Oppenheimer-Shaanan, Ilana Kaspy

    Affiliation: Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Nir London,

    Affiliation: Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Ora Schueler-Furman,

    Affiliation: Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Eylon Yavin,

    Affiliation: Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Gad Glaser,

    Affiliation: Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Joshua Katzhendler,

    Affiliation: Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Sigal Ben-Yehuda mail

    sigalb@ekmd.huji.ac.il

    Affiliation: Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel

    X
  • Published: September 20, 2012
  • DOI: 10.1371/journal.ppat.1002925

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.